Comparison of the clinical manifestations of type 2 diabetes mellitus between rhesus monkey (Macaca mulatta lasiotis) and human being

Pancreas

Volumn 42, Issue 3, 2013, Pages 537-542

  Gong, Li ^a   Zeng, Wen ^b   Yang, Zunyuan ^a   Chen, Zhengli ^c   Cheng, Anchun ^b   Shen, Yubo ^a   Zeng, Licai ^b   Luo, Qihui ^c   Yang, Yang ^a  

^a Sichuan Industrial Institute of Antibiotics   (China)

^b SICHUAN AGRICULTURAL UNIVERSITY   (China)

^c KEY LABORATORY OF ANIMAL DISEASE AND HUMAN HEALTH OF SICHUAN PROVINCE   (China)

Author keywords

Clinical manifestations; Rhesus monkey (M. m. lasiotis); Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BODY WEIGHT; CLEARANCE; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FASTING; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MACACA MULATTA; MALE; OBESITY;

EID: 84884213258     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182732501     Document Type: Article

References (30)

1. Scheen AJ. Diabetes mellitus in the elderly: Insulin resistance and or impaired insulin secretion? Diabetes Metab. 2005;31:5S27-5S34.
2. van Haeften TW. Early disturbances in insulin secretion in the development of type 2 diabetes mellitus. Mol Cell Endocrinol. 2002; 197:197-204.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
4. Roglic G, Unwin N. Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Res Clin Pract. 2010;87:15-19.
5. Ridderstrale M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol. 2009;297:10-17.
6. Stettler R, Ith M, Acheson KJ, et al. Interaction between dietary lipids and physical inactivity on insulin sensitivity and on intramyocellular lipids in healthy men. Diabetes Care. 2005;28:1404-1409.
7. Sullivan PW, Ghushchyan VH, Ben-Joseph R, et al. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008;17:1063-1071.
8. Di Carli MF, Janisse J, Grunberger G, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387-1393.
9. Sima AA, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol. 2004;490:187-197.
10. Morrish NJ, Wang SL, Stevens LK, et al. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(suppl 2):S14-S21.
11. World Health Organization. Prevention of blindness from diabetes mellitus: Report of a WHO consultation. World Health Org, Geneva 2005.
12. American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care. 2010;33:S62-S69.
13. World Health Organization/International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation. World Health Org Geneva 2006.
14. Söderberg S, Zimmet P, Tuomilehto J, et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med. 2004;256:37-47.
15. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108-1112.
16. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European Cohorts. Diabetes Care. 2003;26:61-69.
17. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med. 2005;353:1454-1462.
18. Levitan EB, Song Y, Ford ES, et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med. 2004;164:2147-2155.
19. Bruns DE, Knowler WC. Stabilization of glucose in blood samples: why it matters. Clin Chem. 2009;55:850-852.
20. Miller WG, Myers GL, Ashwood ER, et al. State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. Arch Pathol Lab Med. 2008;132:838-846.
21. Burrin JM, Alberti KG. What is blood glucose: Can it be measured? Diabet Med. 1990;7:199-206.
22. Wagner JE, Kavanagh K,Ward GM, et al. Old world nonhuman primate models of type 2 diabetes mellitus. ILAR J. 2006;47:259-271.
23. Ding SY, Tigno XT, Hansen BC. Nuclear magnetic resonancedetermined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. Metabolism. 2007;56:838-846.
24. Hansen BC, Bodkin NL. Heterogeneity of insulin responses: Phases leading to type 2 (nonYinsulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia. 1986;29:713-719.
25. Tigno XT, Gerzanich G, Hansen BC. Age-related changes in metabolic parameters. J Gerontol A Biol Sci Med Sci. 2004;59:1081-1088.
26. ZengW, Cheng AC, Chen ZL, et al. In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration. Acta Pharmacol Sin. 2009;30:1666-1673.
27. National Institutes of Health. Clinical guidelines on the identification evaluation, and treatment of overweight and obesity in adultsVthe evidence report. Obes Res. 1998;6(suppl 2):51SY209S.
28. Brunzell JD, Robertson RP, Lemer RL, et al. Relationship between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976;42:222-229.
29. Bergstrom RW, Wahl PW, Leonetti DL. Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab. 1990;71:1447-1453.
30. Guillausseau PJ, Meas T, Virally M, et al. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab. 2008; 34(suppl 2):S43-S48.